Position in RXRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$17,462,723
+$5,279,704 QoQ
Shares Held
4,758,236
+19.9% QoQ
Ownership
0.889%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 344 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. RXRX ranks #86 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in RXRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,462,723 | 4,758,236 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $12,183,019 | 3,968,411 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $14,069,389 | 3,439,949 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $16,286,001 | 3,337,296 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $14,749,250 | 2,914,872 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $12,670,542 | 2,395,188 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $16,186,892 | 2,394,511 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $13,329,097 | 2,022,625 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $9,859,574 | 1,314,610 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $12,828,297 | 1,286,690 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $12,774,486 | 1,295,587 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $10,013,329 | 1,308,932 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $9,352,341 | 1,251,987 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $7,709,031 | 1,155,777 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $8,941,308 | 1,159,703 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $12,062,545 | 1,133,698 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,987,634 | 981,282 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $6,154,334 | 859,544 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $15,176,510 | 885,961 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $5,767,939 | 250,671 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,846,723 | 242,376 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||